Alphamol Science Ltd. (shanghai)

This early-stage study tests a single dose of Alpha-0261 tablets in 60 healthy adults aged 18 to 55. The main goal is to check safety and how the drug moves through the body. No treatment is given for any disease; this is a first step to see if the drug is safe enough for future …